Robert F. Kennedy Jr. has expanded his vaccine oversight panel, adding more experts to review safety data amid ongoing legal challenges against his advocacy. The move comes as his organization faces lawsuits over alleged misinformation claims regarding vaccine safety. While the initiative aims to bolster public trust in vaccine regulation, it could further polarize public opinion and impact healthcare sector investments. Market participants are monitoring potential regulatory shifts in pharmaceutical and biotech industries.